Back

Antiplatelet agents in patients with intermediate coronary artery stenosis and deferred revascularization

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Functional testing in coronary artery disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor David Hong

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Clinical value of single projection angiography-derived FFR in non-infarct related artery
Assistant Professor S. Lee (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
Influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of percutaneous coronary intervention
Doctor D. Munhoz (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of microvascular resistance reserve in symptomatic patients with intermediate coronary stenosis
Associate Professor J. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
VERMONT non-optimised: can baseline diagnostic catheter images be used to measure angiography based CAAS-vFFR?
Doctor D. Akrawi (London, GB)
Abstract Slides Video
Presentation thumbnail
Fractional flow reserve versus solely angiography-guided revascularisation in coronary artery disease, systematic review and meta-analysis.
Mr M. Blaziak (Wroclaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Functional testing in coronary artery disease
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources